12 hrs ago | Seeking Alpha
Can These 5 Dividend Stocks Deliver?
The following five companies all yield big dividends. To continue paying dividends at high rates, companies need to have growing or stable earnings that equate to positive cash flows.
Expecting Gilead To Break $70, Outperforming Merck
Since I first promoted Gilead Sciences in my bullish article here , the stock has taken off like a rocket and gained 40.8%, beating the Dow Jones more than 6x over.
Healthcare Sector Review: Watson Files for FDA Approval, Biosimilar Drug Guidelines
Johnson & Johnson , Pfizer Inc. A ,A Amgen, Inc. A : The FDA released guidelines for the first shortcut to the U.S. market for "biosimilar" drugs, less expensive versions of expensive and complex medicines made from biological matter.
Robert Woods Johnson Rahway Foundation to honor hospital board member
RWJ Rahway Foundation and the Rose Ball Committee are pleased to announced Larry Naldi, RWJ Rahway Board of Governors member and Senior Vice President Strategy & Integration at Merck & Co, Inc., is being inducted into the 2012 Guardians of the Rose.
These 5 Giants Are Outperforming The Market
The Fed's promise of low interest rates is exciting news to both investors and companies.
New Leader an Optimum Fit for Washington Wine Group
Kennewick, Wash. - A new leader with deep knowledge of science, finance and marketing was chosen as executive director of the Washington Wine Commission .
Vanguard's Top High-Yield Holdings: 2 To Buy, 3 To Avoid
The Vanguard Group is an American investment management company managing approximately $1.6 trillion in assets.
Baldness-treating drugs caused sexual dysfunction, suit against Merck claims
More than 50 people have joined a lawsuit accusing the manufacturers of drugs used to treat male pattern baldness of failing to warn patients about dangerous side effects.
Merck & Co., Inc. Open to More Indian JVs
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Global pharma major Merck, which formed a joint venture with Sun Pharma, said that it was open for more alliances/ partnerships with other Indian companies as part of the ... (more)
Lorillard: A 5.5% Yielder Gaining Momentum
I posted an article back in August about the attractiveness of buying low-beta stocks with solid dividends .
Regulators set a course for drug makers eager to enter biosimilars market
The FDA released long-awaited guidance for drug makers who are poised to jump into the market for biosimilars, lower-priced versions of complex biologic medicines.
Consider These 5 Stocks For The Long Term
I have identified five interesting stocks that recently reported earnings. While Electronic Arts lost money, Merck , Boston Scientific , Las Vegas Sands , and Qualcomm were able to generate income.
Merck says hepatitis pill hampers HIV Drugs
Merck & Co's recently approved Victrelis treatment for hepatitis C considerably lessens the effectiveness of some widely used medicines against the virus that causes AIDS, Merck and U.S. regulators said in separate reports.
Washington State Wine Commission hires new Executive Director
Mr. Warner comes to the Commission from Merck & Co., Inc., where he was Managing Director based in Bucharest, Romania.
Thomas E. Shenk to Retire from Merck & Co., Inc.'s Board of Directors
Dr. Shenk is leaving the board to focus on the new company he is forming to commercialize discoveries made in his Princeton University laboratory in the area of antiviral therapeutics.
5 Pharmaceutical Stocks To Consider Now
Pharmaceutical companies remain under pressure as they deal with increased competition from each other, which threatens their market share.
Merck & Co., Inc. Rotavirus Vaccine Not Linked to Bowel Problems in Study
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia A new study further eases fears that the rotavirus vaccine might increase the risk of blocked bowels in infants -- a concern that led to an earlier version of the vaccine being ... (more)
Healthcare Biz Review: Novartis AG, Johnson & Johnson, Pfizer, and...
Merck announces that top-line results of a study on Vorapaxar show that the drug significantly reduced the risk of cardiovascular events.
5 Disturbingly Expensive Stocks
What follows is a list of companies with PE ratios above 20, typically indicative of an expensive stock .
Merck anti-clot compound again shows increased bleeding risk
An experimental anti-clotting drug that Readington-based Merck & Co. is developing was found to increase risk of dangerous internal bleeding in a second study, meaning it's unlikely to achieve the blockbuster status once expected - if it's even approved.